Premium
Letter: elevated liver enzymes and outcomes in COVID Authors' reply
Author(s) -
Kulkarni Anand V.,
Kumar Pramod,
Tevethia Harsh Vardhan,
Arab Juan Pablo,
Candia Roberto,
Premkumar Madhumita,
Sharma Mithun,
Rao Padaki Nagaraja,
Reddy Duvvuru Nageshwar
Publication year - 2020
Publication title -
alimentary pharmacology and therapeutics
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 3.308
H-Index - 177
eISSN - 1365-2036
pISSN - 0269-2813
DOI - 10.1111/apt.16028
Subject(s) - medicine , covid-19 , elevated liver enzymes , liver enzyme , betacoronavirus , coronavirus infections , medline , virology , gastroenterology , biochemistry , genetics , biology , pregnancy , disease , outbreak , infectious disease (medical specialty)
LINKED CONTENT This article is linked to Kulkarni et al and Elhence et al papers. To view these articles, visit https://doi.org/10.1111/apt.15916 and https://doi.org/10.1111/apt.16010
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom